STRIDE Threat Modeling for Medical Devices

Master STRIDE threat modeling for medical devices. Learn to identify risks, meet FDA premarket requirements, and secure your MedTech ecosystem. Read our guide.

This guide is written for medical device manufacturers navigating STRIDE threat modeling medical devices. It is built from real submissions, FDA correspondence, and the standards reviewers actually cite. Use it as a working reference: read straight through, jump to the section that matches your current gap, or hand it to your engineering and regulatory leads as a checklist.

Introduction to STRIDE in the Medical Device Context

Introduction to STRIDE in the Medical Device Context is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Why Threat Modeling is Critical for FDA Premarket Submissions

Why Threat Modeling is Critical for FDA Premarket Submissions. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

How STRIDE Fits into the Secure Product Development Framework (SPDF)

How STRIDE Fits into the Secure Product Development Framework (SPDF). Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Breaking Down the STRIDE Categories for MedTech

Breaking Down the STRIDE Categories for MedTech is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Spoofing: Identity Risks in Connected Devices

Spoofing: Identity Risks in Connected Devices. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Tampering: Maintaining Data Integrity for Patient Safety

Tampering: Maintaining Data Integrity for Patient Safety. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Repudiation: Audit Trails and Accountability

Repudiation: Audit Trails and Accountability. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Information Disclosure: Protecting PHI and Proprietary Data

Information Disclosure: Protecting PHI and Proprietary Data. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Denial of Service: Ensuring Availability of Life-Critical Functions

Denial of Service: Ensuring Availability of Life-Critical Functions. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Elevation of Privilege: Controlling Access in Hospital Environments

Elevation of Privilege: Controlling Access in Hospital Environments. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

The 4-Step Medical Device Threat Modeling Process

The 4-Step Medical Device Threat Modeling Process is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Step 1: Decomposing the System (Data Flow Diagrams)

Step 1: Decomposing the System (Data Flow Diagrams). Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Step 2: Applying the STRIDE Mnemonic to Components

Step 2: Applying the STRIDE Mnemonic to Components. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Step 3: Risk Assessment and Mitigation Strategies

Step 3: Risk Assessment and Mitigation Strategies. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Step 4: Validation and Traceability for Regulatory Audits

Step 4: Validation and Traceability for Regulatory Audits. Make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

Common STRIDE Pitfalls in MedTech Submissions

Common STRIDE Pitfalls in MedTech Submissions is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Integrating STRIDE with AAMI TIR57 and ISO 14971

Integrating STRIDE with AAMI TIR57 and ISO 14971 is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

Conclusion: From Threat Model to Secure Architecture

Conclusion: From Threat Model to Secure Architecture is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

How Blue Goat Cyber Approaches STRIDE threat modeling medical devices

We treat STRIDE threat modeling medical devices as a regulated engineering workstream, not a one-time document drop. Every engagement is led by senior medical-device security engineers who have shipped 250+ FDA cybersecurity submissions across 510(k), De Novo, PMA, and EU MDR pathways. Here is how we run it end to end:

• Scoping against your device profile. We baseline connectivity, interfaces, data flows, and intended use before we touch a template - because reviewer expectations for a Class II wearable are not the same as a networked hospital platform.
• Standards mapping in writing. Every deliverable is traced to the February 2026 FDA premarket cybersecurity guidance, AAMI SW96, AAMI TIR57 / TIR97, IEC 81001-5-1, and ISO 14971 - with the citation in the artifact itself so reviewers do not have to guess.
• Evidence generated inside your QMS. Threat models, SBOMs, security risk assessments, and test reports are versioned under design controls so the traceability from requirement → test → residual risk holds up under audit.
• Independent testing where it counts. Penetration testing and vulnerability analysis are executed by a testing team that does not also write the design - the separation FDA reviewers increasingly expect on cyber devices.
• Deficiency-ready posture. We anticipate the RTA, AI-letter, and Major deficiency patterns FDA has issued over the past 24 months and pre-empt them in the initial submission, cutting the odds of a second review cycle.
• Postmarket handoff, not abandonment. Every premarket package leaves you with a working postmarket monitoring plan, CVD process, and update cadence so the evidence you shipped stays defensible after clearance.

If you want that treatment applied to your STRIDE threat modeling medical devices package, our FDA Premarket Cybersecurity Services and FDA Cybersecurity Deficiency Response engagements are the two most common entry points.

Frequently asked questions

Is STRIDE required by the FDA for medical device submissions?

Short answer: It depends on the device classification, intended use, and connectivity profile. But the controlling references are FDA's February 2026 premarket guidance, AAMI SW96, and IEC 81001-5-1. The sections above walk through how each applies. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How do you create a Data Flow Diagram (DFD) for a medical device?

Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

What is the difference between STRIDE and PASTA for MedTech?

Short answer: STRIDE threat modeling medical devices is a discrete deliverable inside the Secure Product Development Framework (SPDF). FDA expects it documented, traceable, and version-controlled inside your QMS. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

How does threat modeling relate to medical device risk management (ISO 14971)?

Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

What level of detail does the FDA expect in a threat model?

Short answer: It depends on the device classification, intended use, and connectivity profile. But the controlling references are FDA's February 2026 premarket guidance, AAMI SW96, and IEC 81001-5-1. The sections above walk through how each applies. For the full context, work through the relevant section above and the linked services below. Every answer here is grounded in current FDA guidance and the standards your reviewer is using.

Where this fits in the cluster

This page sits downstream of our pillar resources on STRIDE threat modeling medical devices. If you arrived here from a different starting point, these are the most useful adjacent pages:

• Medical Device Threat Modeling
• 12 Critical Threat Modeling Gaps in Medical Device Submissions
• Secure MedTech Product Design Consulting
• The SPDF Playbook for FDA-Ready Medical Devices

Related from Blue Goat Cyber

• FDA Premarket Cybersecurity Services
• Medical Device Penetration Testing
• 12 Critical Threat Modeling Gaps in Medical Device Submissions
• FDA-Compliant SBOM Services
• The MedTech Cybersecurity Standards Decoder

Sources & primary references

• Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions. U.S. Food and Drug Administration (FDA)
• NIST SP 800-154: Guide to Data-Centric System Threat Modeling. NIST (National Institute of Standards and Technology)
• Principles and Practices for Medical Device Cybersecurity. International Medical Device Regulators Forum (IMDRF)

Talk to a regulatory cybersecurity team

If you are working through STRIDE threat modeling medical devices and want a second pair of eyes on your submission package, we ship cybersecurity deliverables for medical device manufacturers across 510(k), De Novo, PMA, and EU MDR pathways. Book a discovery session and we will walk your evidence with you.